SAWAF AZIZ (SVP & CHIEF FINANCIAL OFFICER) reported 3 transactions at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/25/2026ACC: 0001961289-26-000011
Officer· SVP & CHIEF FINANCIAL OFFICER
Since Feb 2026
-336.84K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
336.84K disposed
Non-Derivative Transactions3
Ordinary Shares
Direct
Shares
−204.97K
Price / share
—
Trade value
—
% of position
60.8%
9/23/2026
336.84K→131.88K
Ordinary Shares
Direct
Shares
−108.44K
Price / share
—
Trade value
—
% of position
82.2%
9/23/2026
131.88K→23.44K
Ordinary Shares
Direct
Shares
−23.44K
Price / share
—
Trade value
—
% of position
New position
9/23/2026
23.44K→0.00
Total
Net shares
−336.84K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 9/23/2026 | D · Disposition | −204.97K | — | — | 60.8% | 336.84K | 131.88K |
| Ordinary Shares Direct | 9/23/2026 | D · Disposition | −108.44K | — | — | 82.2% | 131.88K | 23.44K |
| Ordinary Shares Direct | 9/23/2026 | D · Disposition | −23.44K | — | — | New position | 23.44K | 0.00 |
| Total | −336.84K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported